Josh Blackman is a highly adaptable interim management specialist with over a decade of experience placing senior leaders and board members in healthcare, life sciences and social impact sectors. Known for navigating complex client requirements, Josh has a deep network within his sector, enabling him to deliver impactful, lasting interim executive solutions for organisations undergoing transformation
Introduction
In the highly regulated and fast-evolving medical device sector, family-owned firms must remain agile while achieving sustainable growth. This case study explores how Boyden partnered with a British family-owned medical device manufacturer to appoint an Interim Operations Director, enabling operational modernisation, transformation and growth readiness.
Background
The Company earned a reputation for innovative products but faced mounting challenges from international expansion and product innovation. The board acknowledged the need to evolve operational infrastructure, shifting from a founder-led, familial approach to a more corporate and performance-focused model.
Challenges
Boyden’s assessment highlighted several core challenges:
- Legacy systems and processes constrained scalability
- Rising demand and regulatory scrutiny demanded enhancements in manufacturing capacity and quality assurance
- Reduced experienced operational leadership limited transformation speed
- The transition to a culture of accountability and evidence-based decisions required careful change management
Actions Taken
Working closely with the board and family stakeholders, Boyden defined the profile for an interim Operations Director with sector expertise and proven transformation capability. The interim leader was empowered to tackle the following:
A thorough audit of manufacturing, supply chain and quality processes identified inefficiencies and prioritised improvement initiatives. Detailed workflow mapping enabled the development of a clear operational roadmap.
Lean principles were introduced to drive process efficiency, reduce waste and increase output. New key performance indicators provided real-time oversight and enabled proactive decision-making.
A structured programme was launched to enhance quality systems and documentation, ensuring readiness for external audits. Staff training reinforced a culture of quality and compliance throughout the business.
The interim leader directed expansion initiatives, including the adoption of new technologies and automation. Cross-functional teams were engaged to embed changes while respecting the heritage of the business.
Consistent engagement with family owners, the board and operational teams underpinned the assignment. Facilitated workshops and open communication built consensus and encouraged transparency. The interim’s neutrality and expertise fostered trust and enabled the development of future operational leaders.
Results
The intervention delivered measurable benefits.
- Increased manufacturing efficiency and improved product quality
- Achievement of full regulatory compliance and successful audit outcomes
- Cost savings through streamlined processes and reduced operational waste
- Emergence of a new cohort of operational leaders to champion ongoing improvement
- Stronger foundation for future growth supported by robust, scalable systems and a culture of accountability
Conclusion
Boyden’s partnership with the Company demonstrates the transformational impact of interim leadership in a family-owned medical device business. Appointing an experienced interim Operations Director facilitated operational professionalisation, ensured compliance excellence and unlocked new growth potential. This case illustrates the value that impartial external expertise delivers in enabling significant organisational change for family enterprises.
